Summary
Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The German pharmaceuticals market had total revenues of $78.0m in 2018, representing a compound annual growth rate (CAGR) of 4.9% between 2014 and 2018.
- The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 4.9% for the five-year period 2018-2023, which is expected to drive the market to a value of $99.0m by the end of 2023.
- A tendency for large German pharma companies to be risk averse may result in future stagnation of drug development pipelines.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Germany
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the Germany pharmaceuticals market by value in 2018?
- What will be the size of the Germany pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the Germany pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Germany’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Boehringer Ingelheim GmbH
Novartis AG
F. Hoffmann-La Roche Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Germany pharmaceuticals market value: $ billion, 2014-18
Table 2: Germany pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: Germany pharmaceuticals market share: % share, by value, 2018
Table 4: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: key financials ($)
Table 11: Boehringer Ingelheim GmbH: key financials (€)
Table 12: Boehringer Ingelheim GmbH: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: F. Hoffmann-La Roche Ltd: key facts
Table 17: F. Hoffmann-La Roche Ltd: key financials ($)
Table 18: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 19: F. Hoffmann-La Roche Ltd: key financial ratios
Table 20: Germany size of population (million), 2014-18
Table 21: Germany gdp (constant 2005 prices, $ billion), 2014-18
Table 22: Germany gdp (current prices, $ billion), 2014-18
Table 23: Germany inflation, 2014-18
Table 24: Germany consumer price index (absolute), 2014-18
Table 25: Germany exchange rate, 2014-18
List of Figures
Figure 1: Germany pharmaceuticals market value: $ billion, 2014-18
Figure 2: Germany pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: Germany pharmaceuticals market share: % share, by value, 2018
Figure 4: Germany pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in Germany, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in Germany, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in Germany, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2018
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Boehringer Ingelheim GmbH: revenues & profitability
Figure 14: Boehringer Ingelheim GmbH: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability
Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities
